Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Tissue Engineering Technologies, Markets, Forecasts 2018-2028 - Research and Markets

Research and Markets
Posted on: 13 Dec 17

The "Tissue Engineering 2018-2028: Technologies, Markets, Forecasts" report has been added to Research and Markets' offering.

A market forecast for tissue engineered products is provided for the years 2018 - 2028, where the total value for tissue engineered products is predicted to surpass $4.8 billion. This market is broken down into key applications of therapies (clinical use) and tissue models (research use). Key players in both applications are presented, and the value chain and relevant business models are discussed.


The biggest applications for engineered tissues are in research and development, and in medicine. This report discusses the following key applications of tissue engineering:

  • Testing of cosmetics and other consumer goods
  • Drug screening
  • Personalized medicine
  • Regenerative medicine
  • Cell-based biosensors
  • Food and other animal products
  • Aesthetics

Clinical Landscape

A chapter of this report is dedicated to the use of tissue engineering products in medicine. The following classes of tissue engineered therapies are highlighted:

  • Tissue engineered therapies with FDA marketing approval
  • Tissue engineered therapies close to IND submission
  • Competitive landscape of tissue engineered skin
  • Competitive landscape of tissue engineered cartilage

Additionally, a summary of ongoing clinical trials of tissue engineered products is provided, organized by trial phase, tissue type, and sponsor.

The rest of this chapter describes and discusses the dynamics of US and EU markets, with a look at relevant regulatory pathways, exemptions, and loopholes for tissue engineered products, as well as speculations on the future of regulating this novel class of therapy.


A wide range of approaches are still being explored in tissue engineering, and this report covers both the most innovative and cutting-edge techniques as well as more established technologies.

Technologies presented in this report are:

  • Semi-permeable membranes
  • Cell-laden hydrogels
  • 3D bioprinting
  • 3D printing (including thermoplastic extrusion, material jetting, stereolithography, selective laser sintering)
  • Decelluarization and recellularization of organs
  • Phase separation, freeze-drying, solvent casting and particle leaching, gas foaming
  • Electrospinning and melt electrospinning
  • Self-assembly and self-organization.

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Key Opportunities

4. Tissue Engineering Clinical Landscape

5. Markets And Forecasts

6. Tissue Engineering Technologies

7. Established Technologies

8. 3D Bioprinting

9. Scaffold Technologies

10. 3D Printing

11. Decellularized Organs

12. Other Scaffold Technologies

13. Scaffoldless Technologies

14. Tissue Engineering Challenges

For more information about this report visit

View source version on

Business Wire

Last updated on: 13/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.